Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Bruserud

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 1, 1992
Effect of dipyridamole, theophyllamine and verapamil on spontaneous in vitro proliferation of myelogenous leukaemia cellsO Bruserud
Leukemia|September 26, 1997
Serum levels of soluble ICAM-1 in acute leukemia patients with chemotherapy-induced neutropeniaO Bruserud
Clinical Immunology and Immunopathology|January 1, 1987
Dipyridamol inhibits activation of human T lymphocytes in vitroO Bruserud
Leukemia|August 18, 1999
Acute myelogenous leukemia blasts as accessory cells during T lymphocyte activation: possible implications for future therapeutic strategiesO Bruserud
International Journal of Immunopharmacology|February 24, 2000
Effects of imipenem and cilastatin on human T-lymphocytes derived from acute leukemia patients with chemotherapy-induced leucopenia: studies of T-lymphocyte responses in the presence of acute myelogenous leukemia (AML) blast accessory cellsO Bruserud
Leukemia|September 1, 1996
Effects of interleukin-13 on cytokine secretion by human acute myelogenous leukemia blastsO Bruserud
Leukemia Research|January 1, 1996
Effects of endogenous interleukin 1 on blast cells derived from acute myelogenous leukemia patientsO Bruserud
Clinical Immunology and Immunopathology|July 1, 1984
The effect of theophyllamine on T-lymphocyte activation in vitroO Bruserud
Cytokines, Cellular & Molecular Therapy|November 24, 1998
IL-4, IL-10 and IL-13 in acute myelogenous leukemiaO Bruserud
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 20, 1983
[Fever of unknown origin in adults with malignant diseases]O Bruserud
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Acta Oncologica (Stockholm, Sweden)|January 1, 1992
Effect of dipyridamole, theophyllamine and verapamil on spontaneous in vitro proliferation of myelogenous leukaemia cellsO Bruserud
Leukemia|September 26, 1997
Serum levels of soluble ICAM-1 in acute leukemia patients with chemotherapy-induced neutropeniaO Bruserud
Clinical Immunology and Immunopathology|January 1, 1987
Dipyridamol inhibits activation of human T lymphocytes in vitroO Bruserud
Leukemia|August 18, 1999
Acute myelogenous leukemia blasts as accessory cells during T lymphocyte activation: possible implications for future therapeutic strategiesO Bruserud
International Journal of Immunopharmacology|February 24, 2000
Effects of imipenem and cilastatin on human T-lymphocytes derived from acute leukemia patients with chemotherapy-induced leucopenia: studies of T-lymphocyte responses in the presence of acute myelogenous leukemia (AML) blast accessory cellsO Bruserud
Leukemia|September 1, 1996
Effects of interleukin-13 on cytokine secretion by human acute myelogenous leukemia blastsO Bruserud
Leukemia Research|January 1, 1996
Effects of endogenous interleukin 1 on blast cells derived from acute myelogenous leukemia patientsO Bruserud
Clinical Immunology and Immunopathology|July 1, 1984
The effect of theophyllamine on T-lymphocyte activation in vitroO Bruserud
Cytokines, Cellular & Molecular Therapy|November 24, 1998
IL-4, IL-10 and IL-13 in acute myelogenous leukemiaO Bruserud
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 20, 1983
[Fever of unknown origin in adults with malignant diseases]O Bruserud
Pageof 11